Display Settings:

Format

Send to:

Choose Destination
    Allergy Asthma Clin Immunol. 2010 Jul 28;6(1):20.

    Management of hereditary angioedema: 2010 Canadian approach.

    Source

    Canadian Hereditary Angioedema Network (CHAEN)/Réseau Canadien d'Angioédème Héréditaire (RCAH), 705 South Tower, 3031 Hospital Dr, NW Calgary, Alberta, Canada. tbowen@pol.net.

    Abstract

    C1-inhibitor (C1-INH) deficiency is a rare blood disorder resulting in angioedema attacks that are debilitating and may be life-threatening. Prophylaxis and therapy of events has changed since our first Canadian Consensus Conference on the diagnosis, therapy and management of HAE. We have formed the Canadian Hereditary Angioedema Network (CHAEN)/Réseau Canadien d'Angioédème Héréditaire (RCAH) - http://www.haecanada.com to advance care of patients with this disorder in Canada. We here present a review of management of HAE in Canada.

    PMID:
    20667123
    [PubMed]
    PMCID: PMC2921103
    Free PMC Article

    Images from this publication.See all images (4) Free text

    Figure 4
    Figure 2
    Figure 1
    Figure 3

      Supplemental Content

      Click here to read Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk